Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • maembe
    Junior Member
    • Jun 2012
    • 2

    comparison of R/Bioconductor microarray analysis with other statistical tools

    Hey,

    Am new here, so i think its appropriate to say a humble hallo..

    secondly, am also new to bioinformatics but i have managed to do some analysis in the past few weeks. my main aim was to compair two groups of patients to determine genes which were differentially expressed from the two groups. i did the analysis on Pertek and also on R/Bioconductor.
    am however observing something wierd; the results are not comparable. I'm getting more genes when using the commercial software compared to when i use R/bioconductor.

    Can someone give me a heads up on what might be going on here..
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    That is not entirely unexpected unless the difference in numbers you are observing is very large.

    Have you compared the exact methods that the partek analysis used with the R/bioconductor? Even then there may be subtle differences in how a method is coded in software.

    Comment

    • maembe
      Junior Member
      • Jun 2012
      • 2

      #3
      Pertek uses ANOVA to determine all differentially expressed genes, by calculating the F-statistics critical value. On the other hand, for R/Bioconductor, i used DEGexp function, in the DEGseq library to get my gene list. Now, i acheved this by splitting the whole dataset containing gene expression values into two groups then loaded them onto DEGexp funtion. I am not sure if it can be considered as the correct approach.

      with R/Bioconductor, i could only get 200 genes at a p-value of 0.05, yet Pertek gave me close to 5000 genes.I'm totally confused since i dont know which results to trust

      Your comments will be appreciated
      Kind regards

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 12:17 PM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      37 views
      0 reactions
      Last Post SEQadmin2  
      Working...